Stay tuned
Takeda takes $2.5B legal charge after pay-for-delay verdict, swings to loss for '25
The company adjusted its full-year 2025 earnings to account for a leg
As pro-life pressure ramps up on Trump, FDA is investigating safety of abortion pill: WSJ
The FDA is going forward with an investigation into the safety o
Behind the headlines of ASCO 2026
Each year, the global oncology community descends on Chicago for ASCO
At first public hearing for FDA’s CNPV program, industry support meets ‘deep concern’ from experts
On Thursday, the public had the first chance to air their grievances
It's unanimous: SCOTUS agrees with Hikma in 'skinny label' case vs. Amarin
With a resounding unanimous vote, the U.S. Supreme Court has sided wi
Stay tuned
© 1994 - 2026 B.M. Pharmaceuticals